Cerenion Oy
Healthcare Software · Finland · 11-50 Employees
View Company Info for Free
Overview
Headquarters
Elektroniikkatie 3, Oulu, Northern Ostro...Phone Number
+358 504474909Website
www.cerenion.comRevenue
<$5 MillionIndustry
ZI Rank: 1
Signal Type
Mar
Apr
May
Jun
Jul
Aug
ZI Rank
1
1
1
1
1
1
About Cerenion Oy
Cerenion specializes in innovative brain monitoring solutions, primarily through their C-Trend® software, which simplifies EEG readings for improved bedside care in intensive healthcare settings. Their mission focuses on making EEG monitoring more accessible, recognizing its critical role in patient recovery, especially for those at risk of seizures or cerebral hypoxia. The C-Trend tool utilizes AI to convert complex EEG data into clear numerical parameters, aiding healthcare professionals in detecting and responding to brain-threatening changes effectively. Cerenion’s products are CE-marked for quality and safety, supporting acute care for critically ill patients across Europe.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is Cerenion Oy your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Click to see if Cerenion Oy had a recent Job posting/layoffs
Check if Cerenion Oy has recently received funding, and reach out quickly before it becomes old news!
Funding: Get notified immidiatlly once Cerenion Oy has new funding data
Website visits: Recent activity has been detected on your website
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Product Launch: Get notified when Cerenion Oy launches new products
Check out if Cerenion Oy is spiking on competitors!
Earning: See what the market has to say on Cerenion Oy recently announced quarterly report
Congratulate Masked Content for being promoted to Masked Content at Cerenion Oy
Cerenion Oy, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Introduce yourself to Masked Content, who has shown a strong intent to purchase lately
Find 3 more new buyers
Company Profile Activity
Activity Insights
Cerenion Oy is experiencing very low activity levels compared to other companies in the Software sector.
What does this means?
Cerenion Oy is drawing exceptional interest within the Software industry, suggesting notable developments or strong market momentum, learn more about Cerenion Oy.
Cerenion Oy financials insights
Gather financial insights about Cerenion Oy, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2019
Angel/Seed
$1.6M
Cerenion Oy Tech Stack
A closer look at the technologies used by Cerenion Oy
See more technologies
Cerenion Oy News & Media
Bittium and Cerenion announce collaboration on bringing next-generation brain monitoring to intensive care
Press release Free for publication on May 30, 2018 at 11am (CEST +1) Bittium and Cerenion announce collaboration on bringing next-generation brain monitoring to intensive care Oulu, Finland, May 30, 2018 – Bittium BioSignals Ltd, a subsidiary of Bittium Corporation, and Cerenion Oy announce a collaboration project on bringing advanced brain monitoring into the array of vital signs monitoring available to intensive care staff. The collaboration aims on providing a comprehensive solution for brain
Read more news
Top Healthcare Software Companies
Top companies in Canada by revenue
Top companies in Australia by revenue
Top companies in New Zealand by revenue
Frequently Asked Questions Regarding Cerenion Oy
Sign Up For FreeTo access detailed company insights
Cerenion specializes in innovative brain monitoring solutions, primarily through their C-Trend® software, which simplifies EEG readings for improved bedside care in intensive healthcare settings. Their mission focuses on making EEG monitoring more accessible, recognizing its critical role in patient recovery, especially for those at risk of seizure... Read More
